Fall is here, which means respiratory viruses like flu, RSV and COVID are expected to keep spreading as weather cools and more people gather indoors. Luckily, we've got vaccines in stock to help ...

After two years characterized by layoffs, pipeline reorganizations, FDA delays and clinical holds, Novavax CEO John Jacobs ...

The two vaccines induce the immune system to target a critical protein on the surface of RSV, the F protein ... board fees from AstraZeneca and Novavax. Segev reports receiving consulting fees ...

New York Amsterdam News | Word In Black (WIB) - With the triad of respiratory viruses present in our day-to-day, it ...

The adjuvanted RSV prefusion F protein-based vaccine RSVPreF3-AS01E Arexvy was ... and serving on the advisory boards of AstraZeneca and Novavax; consulting fees from the CDC and the Infectious ...

Live-attenuated respiratory syncytial virus (RSV) vaccines are highly immunogenic among HIV-exposed uninfected (HEU) pediatric patients, according to results of a study published in Open Forum ...

U.S.-based vaccine maker Novavax said on Wednesday it will ... expects to see an increase in levels of COVID-19 and respiratory syncytial virus (RSV) in the country in the coming weeks, as they ...